ERBC at ACT 2026

Nov 15–18, 2026 San Antonio, TX ~1.4k attendees Website

ERBC takes part in 1 session at ACT 2026 in San Antonio, and exhibits at Booth 113. Its program centres on cardiac safety, with a study of heart damage caused by the drug milrinone in rats.

OrganizationACT 2026 Attendance
ERBC
Baugy, France
erbc-group.com
Contract research organizations (CROs)
European preclinical contract research organization running efficacy and safety studies for pharmaceutical, chemical and agrochemical clients, with consultancy and alternative methods.
Booth
Exhibiting at Booth 113
Mon, Nov 169:30am–6:30pmTue, Nov 178:00am–4:30pm
Poster
Mon Nov 16
5:00pm–6:30pm
Assessment of Milrinone-Induced Cardiotoxicity in Rats (P119)
Nelson Exhibit Ballroom · Poster P119
Safety pharmacology

Explore the full ACT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Antonio. Leave your work email and we’ll be in touch.

Privacy

Download the full ACT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from ERBC

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American College of Toxicology (ACT). Organization details are derived from ACT’s published program, exhibitor floor plan and supporter list, and each organization’s own website. Submit a correction